Lipocine, Inc. engages in the research and development of treatment for use in men&#x27;s and women&#x27;s health through proprietary drug delivery technologies. It focuses on oral testosterone replacement therapy and preterm birth prevention. The company was founded on July 24, 2013 and is headquartered in Salt Lake City, UT.
